BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16415793)

  • 1. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model.
    Willems SM; Debiec-Rychter M; Szuhai K; Hogendoorn PC; Sciot R
    Mod Pathol; 2006 Mar; 19(3):407-16. PubMed ID: 16415793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.
    Mentzel T; Calonje E; Wadden C; Camplejohn RS; Beham A; Smith MA; Fletcher CD
    Am J Surg Pathol; 1996 Apr; 20(4):391-405. PubMed ID: 8604805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity.
    Willems SM; van Remoortere A; van Zeijl R; Deelder AM; McDonnell LA; Hogendoorn PC
    J Pathol; 2010 Dec; 222(4):400-9. PubMed ID: 20839361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
    Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
    Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
    Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxofibrosarcoma. A study of 30 cases.
    Angervall L; Kindblom LG; Merck C
    Acta Pathol Microbiol Scand A; 1977 Mar; 85A(2):127-40. PubMed ID: 15396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
    Willems SM; Mohseny AB; Balog C; Sewrajsing R; Briaire-de Bruijn IH; Knijnenburg J; Cleton-Jansen AM; Sciot R; Fletcher CD; Deelder AM; Szuhai K; Hensbergen PJ; Hogendoorn PC
    J Cell Mol Med; 2009 Jul; 13(7):1291-301. PubMed ID: 19320777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
    Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
    Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.
    Mertens F; Dal Cin P; De Wever I; Fletcher CD; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van Den Berghe H; Vanni R; Willén H
    J Pathol; 2000 Jan; 190(1):31-8. PubMed ID: 10640989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
    Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
    Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation.
    Ohguri T; Hisaoka M; Kawauchi S; Sasaki K; Aoki T; Kanemitsu S; Matsuyama A; Korogi Y; Hashimoto H
    J Clin Pathol; 2006 Sep; 59(9):978-83. PubMed ID: 16751306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxofibrosarcoma in adolescents and young adults: a clinicopathologic study of 17 cases.
    Arispe Angulo KR; Logan S; Bahrami A; John I; Billings SD; Agrawal S; Bena J; Mesko N; Folpe AL; Fritchie KJ
    Hum Pathol; 2023 Dec; 142():90-95. PubMed ID: 37742946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome maintenance protein in myxofibrosarcoma.
    Sington JD; Freeman A; Morris LS; Vowler SL; Arch BN; Fisher C; Coleman N
    Mod Pathol; 2004 Feb; 17(2):235-40. PubMed ID: 14685255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sinonasal myxofibrosarcoma: a clinicopathological study of five cases and review of the literature.
    Dermawan JK; Whaley RD; Gjeorgjievski SG; Habeeb O; Billings SD
    Pathology; 2022 Feb; 54(1):63-70. PubMed ID: 34303554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].
    Mentzel T; Katenkamp D; Fletcher CD
    Pathologe; 1996 Mar; 17(2):116-21. PubMed ID: 8650138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
    Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
    Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study.
    Bridge RS; Bridge JA; Neff JR; Naumann S; Althof P; Bruch LA
    J Clin Pathol; 2004 Nov; 57(11):1172-8. PubMed ID: 15509679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.